A quick and accurate method for the estimation of covariate effects based on empirical Bayes estimates in mixed-effects modeling: Correction of bias due to shrinkage

Abstract

Nonlinear mixed-effects modeling is a popular approach to describe the temporal trajectory of repeated measurements of clinical endpoints collected over time in clinical trials, to distinguish the within-subject and the between-subject variabilities, and to investigate clinically important risk factors (covariates) that may partly explain the between-subject variability. Due to the complex computing algorithms involved in nonlinear mixed-effects modeling, estimation of covariate effects is often time-consuming and error-prone owing to local convergence. We develop a fast and accurate estimation method based on empirical Bayes estimates from the base mixed-effects model without covariates, and simple regressions outside of the nonlinear mixed-effect modeling framework. Application of the method is illustrated using a pharmacokinetic dataset from an anticoagulation drug for the prevention of major cardiovascular events in patients with acute coronary syndrome. Both the application and extensive simulations demonstrated that the performance of this high-throughput method is comparable to the commonly used maximum likelihood estimation in nonlinear mixed-effects modeling.

Keywords

Nonlinear mixed-effects model covariate analysis empirical Bayes estimates shrinkage population analysis

Get full access to this article

View all access options for this article.

References

Collins

Varmus

. A new initiative on precision medicine. N Engl J Med 2015; 372: 793–795.

Pinheiro

Bates

. Mixed-effects models in S and S-PLUS, New York: Springer, 2000.

Barbolosi

Ciccolini

Lacarelle

, et al. Computational oncology – mathematical modelling of drug regimens for precision medicine. Nat Rev Clin Oncol 2016; 13: 242–254.

Ding

. Population HIV-1 dynamics in vivo: applicable models and inferential tools for virological data from AIDS clinical trials. Biometrics 1999; 55: 410.

Ryan

Stuyckens

, et al. Modeling the relationship between exposure to abiraterone and prostate-specific antigen dynamics in patients with metastatic castration-resistant prostate cancer. Clin Pharmacokinet 2016; 56: 1–2.

Duan

. Applications of population pharmacokinetics in current drug labelling. J Clin Pharm Ther 2007; 32: 57–79.

Min

Yang

, et al. Further evaluation of covariate analysis using empirical Bayes estimates in population pharmacokinetics: the perception of shrinkage and likelihood ratio test. AAPS J 2017; 19: 264–273.

Davidian

Giltinan

. Nonlinear models for repeated measurement data: an overview and update. J Agr Biol Envir St 2003; 8: 387–419.

Savic

Karlsson

. Importance of shrinkage in empirical Bayes estimates for diagnostics: problems and solutions. AAPS J 2009; 11: 558–569. .

10.

Sheiner

Beal

. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data. J Pharmacokinet Biopharm 1980; 8: 553–571.

11.

Vonesh

Carter

. Mixed-effects nonlinear regression for unbalanced repeated measures. Biometrics 1992; 48: 1–17.

12.

Lindstrom

Bates

. Nonlinear mixed effects models for repeated measures data. Biometrics 1990; 46: 673–687.

13.

Pinheiro

Bates

. Approximations to the log-likelihood function in the nonlinear mixed-effects model. J Comput Graph Stat 1995; 4: 12–35.

14.

Bertrand

Comets

Laffont

, et al. Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm. J Pharmacokinet Pharmacodyn 2009; 36: 317–339.

15.

INRIA (Institut National de la Recherche en Informatique et Automatique). Monolix 2018R1 User guide, http://monolix.lixoft.com/single-page/ (2018).

16.

Faxon DP, Creager MA, Smith SC, et al. Atherosclerotic Vascular Disease Conference: Executive Summary: Atherosclerotic Vascular Disease Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association. Circulation 2004; 109: 2595–2604.

17.

Alan

Dariush

Véronique

, et al. Heart disease and stroke statistics 2014 update: a report from the American Heart Association. Circulation 2014; 129: e28.

18.

Donald

Martin

Alexa

, et al. Lifetime risk of developing coronary heart disease. Lancet 1999; 353: 89–92.

19.

Efroymson

. Multiple regression analysis: mathematical methods for digital computers, New York: Wiley, 1960.

20.

Combes

Retout

Frey

, et al. Powers of the likelihood ratio test and the correlation test using empirical Bayes estimates for various shrinkages in population pharmacokinetics. CPT Pharmacometr Syst Pharmacol 2014; 3: e109.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.89 MB